Ottawa Heart Institute

Ottawa, Ontario KIY 4W7

3 studies enrolling now · 22 studies all time

What they study most

Aortic Stenosis, Atherosclerosis, Atrial Fibrillation, Bleeding, Calcium Release Deficiency Syndrome, Calcium Release Deficiency Syndrome (CRDS), Cardiac Surgery, Cardiac Valve Replacement Complication, Cardiovascular Disease, Cardiovascular Diseases, Coronary Artery Disease, Coronary Stenosis

Studies at this site

• International CRDS Registry — Recruiting now
• Evaluation of A Clinical Diagnostic Test for CRDS — Recruiting now
• The Canadian CABG or PCI in Patients With Ischemic Cardiomyopathy Trial (STICH3C) — Recruiting now
• Comparing PFO Outcomes of the Occlutech Flex II PFO Occluder to Standard of Care PFO Occlusion — Running, not enrolling
• HEARTBiT: Multi-Marker Blood Test for Acute Cardiac Transplant Rejection — Completed
• Watchman for Patients With Atrial Fibrillation Undergoing Transcatheter Mitral Valve Repair (WATCH-TMVR) — Completed
• Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial — Running, not enrolling
• Amplatzer Amulet LAAO vs. NOAC — Running, not enrolling
• CardiAMP™ Cell Therapy for Heart Failure Trial — Completed
• Efficacy of Implantable Defibrillator Therapy After a Myocardial Infarction — Completed
• Randomized On-X Anticoagulation Trial — Completed
• TRILUMINATE Pivotal Trial — Running, not enrolling
• ILUMIEN IV: OPTIMAL Percutaneous Coronary Intervention (PCI) — Completed
• COroNary CT Angiography Evaluation For Clinical Outcomes: An InteRnational Multicenter Registry (CONFIRM) — Completed
• Canadian SCAD Study — Status unconfirmed
• Frailty Assessment Before Cardiac Surgery & Transcatheter Interventions — Completed
• Sensor Optimization of Cardiac Resynchronization Therapy Response — Completed
• Aldosterone Antagonist Therapy for Adults With Heart Failure and Preserved Systolic Function — Completed
• Warfarin Versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial — Completed
• Transfusion Requirements in Cardiac Surgery — Completed
• Warfarin and Antiplatelet Therapy in Chronic Heart Failure — Completed
• Protect II, A Prospective, Multicenter Randomized Controlled Trial — Stopped early